日本人の中等症～重症のアトピー性皮膚炎患者における経口JAK阻害薬upadacitinibとステロイド外用薬の併用による安全性【Rising Up 中間解析】
［皮膚科］A phase 3 randomized, multicenter, double-blind study to evaluate the safety of upadacitinib in combination with topical corticosteroids in adolescent and adult patients with moderate-to-severe atopic dermatitis in Japan: An interim 24-week analysis.